ImpriMed
AI-driven precision medicine for oncology, veterinary, and pharma CRO
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
ImpriMed is an AI precision-medicine company that predicts patient-specific drug responses for oncology. It began in veterinary cancer care (canine and feline blood cancers) and also serves human oncology and pharmaceutical CRO use cases with live-cell drug-response testing and precision analytics. Public site: imprimedicine.com.
- Website
- imprimedicine.com
- Stage
- series-a
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- ImpriMed Veterinary Precision Medicine — AI drug-response testing for canine and feline blood cancers · Saas